IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors
Article in Frontiers in Oncology (January 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature
Article in Leukemia & Lymphoma (July 2023)
Therapy-related B-lymphoblastic leukemia after multiple myeloma
Article in Leukemia Research Reports (November 2022)